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Background: Hand osteoarthritis (OA) is one of the most prevalent musculoskeletal diseases in an adult population
and may have a large influence on an individual’s functioning, health-related quality of life and participation in society.
Several studies have demonstrated that exercises may reduce pain and improve functioning in people with knee OA,
with a similar effect suggested for hip OA. For hand OA, available research is very limited and shows conflicting results,
and high-quality randomised controlled trials are warranted.
This paper outlines the protocol for a randomised controlled trial that aims to determine the effect of an exercise
intervention on self-reported hand activity performance in people with hand OA.
Methods: Participants with physician-confirmed hand OA according to the ACR clinical criteria are being recruited
from two Norwegian OA cohorts: the population-based “Musculoskeletal pain in Ullensaker Study” (MUST) OA cohort,
and the hospital-based Oslo Hand OA cohort. Participants are randomised into an intervention- or control group. The
control group receives “usual care”, whereas the intervention group receives a 12-week exercise intervention. The
intervention group attends four group sessions and is instructed to perform the exercise program three times a
week at home. Adherence will be captured using self-report. During the eight weeks with no group sessions, the
intervention group receives a weekly telephone call. The assessments and group sessions are being conducted locally
in Ullensaker Municipality and at Diakonhjemmet Hospital, Oslo. Outcomes are collected at baseline, and at 3 and
6 months. The primary outcome measure is self-reported hand activity performance at 3 months post-randomisation,
as measured by the Functional Index for Hand Osteoarthritis (FIHOA); and a patient-generated measure of disability,
the Patient-Specific Functional Scale (PSFS). Secondary outcome measures are self-reported OA symptoms (e.g. pain,
stiffness and fatigue), the Patient Global Assessment of disease activity, measured hand function (e.g. grip strength,
thumb web space and hand dexterity) and health-related quality of life. Cost-utility and cost-effectiveness
analyses will be conducted.
Discussion: This study will contribute to the knowledge on both the effect and resource use of an exercise programme
with telephone follow-up on self-reported hand activity performance among people with hand OA.
Trial registration: The trial is registered at ClinicalTrials.gov with registration number: NCT01245842.
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Hand osteoarthritis (OA) is a common joint disorder
that may lead to considerable pain and have a substantial
impact on hand function [1]. The consequences of hand
OA are of great importance, at the individual level in the
form of suffering, reduced function and work ability; and
at the societal level in the form of cost for health care
and social security. Research on the Framingham Offspring
and Community cohorts among women and men aged
28–92 years showed that the prevalence of radiographic
hand OA was 51% for women and 48% for men, but that
the prevalence of symptomatic hand OA (both radio-
graphic changes and patient-reported symptoms) was 16%
and 8% for women and men, respectively [2].
Hand OA may lead to pain both in and around af-
fected joints, and a reduction in joint mobility and grip
force, which in turn may result in activity limitations
and participation restrictions [1,3]. The clinical manifes-
tations are represented by soft tissue swelling, bony
enlargements and bone erosions. These findings occur
most frequently in the distal interphalangeal (DIP) and
proximal interphalangeal (PIP) joints of the 2nd-5th fin-
gers, as well as in the carpometacarpal (CMC1) joint of
the thumb. Previous research indicates that levels of pain
and disability are significantly higher among patients
with CMC1 involvement, compared to those without
CMC1 symptoms [4,5].
At present, no OA disease-modifying interventions are
available; therefore, the pharmacological treatment of
hand OA is primarily aimed at alleviating symptoms and
preventing inactivity and functional loss. International
recommendations for OA treatment and standards of
care have been developed to improve hand OA manage-
ment [6,7]. Non-pharmacological approaches are consid-
ered to be the core treatment for OA patients [8];
treatment recommendations for individuals with hand
OA including functional assessments and instructions in
joint protection and work techniques, together with an
exercise regimen, thermal modalities and the use of
assistive devices, braces or joint supports [6,7].
Although there is a considerable amount of research
demonstrating the positive effects of exercise on pain
and function in knee OA [9,10], and also partly in hip
OA [10,11], research on the effects of exercises in people
with hand OA is very limited [12]. Among the few clin-
ical trials that have been done, some have evaluated the
effect of exercise in addition to instructions in joint pro-
tection and splints [13-15]; whereas four studies have
assessed the effect of exercise (including yoga exercises)
alone [16-19]. However, in a recent systematic review
[12] these studies were rated as having a “high risk of
bias” due to methodological limitations such as non-
randomisation allocation procedures or small sample
sizes. Furthermore, some of the studies reported apositive effect of exercises (and splints) on pain, function
or stiffness, while others found no significant effect.
Hence, there is conflicting and very limited evidence for
the effect of exercises on hand OA, and more and better
studies are needed [12,20]. This paper outlines the
protocol for an exercise trial with telephone follow-up
for people with hand OA.
Study objective
A randomised controlled trial (RCT) has been designed
to investigate the effects of a 12-week exercise programme
with telephone follow-up on self-reported hand activity
performance among people with hand OA. Our hypoth-
esis is that the intervention group will report better hand
activity performance at the 3-month follow-up compared
to the control group.
Methods
Study development
The study has been designed by a group of researchers
with a background as occupational therapists or physio-
therapists, and with experience in treating patients with
hand OA and in performing clinical trials. Two patient
research partners and three primary health-care profes-
sionals have also been actively involved in this process.
Study design
The study has been designed as a pragmatic, assessor-
blinded, parallel-group RCT to assess the superiority of a
12-week exercise programme, including telephone follow-
up versus usual care at the 3-month follow-up. Measure-
ments are collected at baseline, and at 3- and 6 months
post-randomisation. The protocol adheres to the SPIRIT
2013 Statement, which defines standard protocol items for
clinical trials [21], and the CONSORT guidelines for
non-pharmacological interventions [22,23]. The study
is designed to conform to the principles of the Declaration
of Helsinki.
Setting
The study is being conducted in two different Norwegian
settings, in the Ullensaker primary health-care services and
at Diakonhjemmet Hospital, Oslo. One occupational ther-
apist in Ullensaker and one at Diakonhjemmet Hospital
are leading the group exercises at the two locations, and
an occupational therapist (ALSS) at Diakonhjemmet
Hospital is performing the telephone follow-up. Physio-
therapists and occupational therapists in Ullensaker
primary health care and at Diakonhjemmet Hospital
are conducting the assessments.
Participants
We aim to recruit 150 persons with hand OA from two
different OA cohorts:
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Osteoarthritis cohort (MUST OA), a cohort of
persons with OA in their hands, hips and/or knees
derived from a population-based postal survey sent
to all inhabitants between 40 to 79 years of age
(n = 12,370) in Ullensaker Municipality in 2010-2011
[24]. Approximately 60% of the individuals with
self-reported hand, hip or knee OA have attended a
comprehensive clinical examination at Diakonhjemmet
Hospital.
2) The Oslo Hand OA cohort, which is a cohort of
Diakonhjemmet Hospital patients between the ages of
60 and 80 years enrolled between 2000 and 2002 [25].
Among these, persons with hand OA in accordance
with the inclusion and exclusion criteria (Table 1) are
being recruited to this RCT, and the recruitment process
is outlined in Figure 1. Participant eligibility is checked
by the principal investigator (NØ), using the clinical
examination data for the MUST OA cohort, and by tele-
phone screening among the Oslo Hand OA cohort. Eli-
gible persons receive written information and a request
to participate in the RCT, and baseline measurements
are taking place on a regular schedule, with 12–18 par-
ticipants each time.Randomisation and allocation concealment
The randomisation schedule was prepared by the study
biostatistician using a computer-generated random num-
bers table, and randomisation is carried out through the
use of random permuted blocks. To help conceal the
randomisation, consecutively numbered and sealed opaque
envelopes prepared by an independent staff member are
used. The envelopes are opened in sequence after the
participant has completed all the baseline measurements.Table 1 Criteria of inclusion and exclusion
Inclusion criteria
• Persons with hand OA according to the ACR classification criteria for
clinical OA [26]:
◦ Pain, aching or stiffness in the hand and 3 of the following:
◦ Hard tissue enlargement involving at least 2 of 10 selected joints
◦ Hard tissue enlargement of at least 2 DIP joints.
◦ Less than 3 swollen MCP joints
◦ Deformity of at least 1 of the 10 selected joints
OR uni-/bilateral OA in the CMC1 joint
• FIHOA* total score ≥5
• Access to a telephone
*The functional index for hand osteoarthritis (FIHOA, range 0–30 (0 = best activity pBlinding
The outcome assessors are blind to group allocation,
and are not involved in providing the interventions. The
written participant information tells participants that
they have an equal chance of being randomised to the
intervention versus the control group, but does not pro-
vide any details of the actual exercise programme. Allo-
cation is revealed to the three occupational therapists
delivering the intervention (group exercises and tele-
phone follow-up), but participants are requested not to
disclose details about their group allocation with the
outcome assessor. The success of outcome assessor
blinding will be evaluated during one group follow-up
assessment for the outcome assessors in Ullensaker and
one at Diakonhjemmet Hospital by asking the assessors
to guess the participants’ group allocation. The statisti-
cian who will perform the main statistical analyses will
be blinded to group allocation during the analyses.Training of research occupational therapists and
physiotherapists
The occupational therapists delivering the intervention
initially participated in a workshop together with three
of the authors (NØ, IK, ALSS) in order to agree on the
principles of the exercise programme, and on the infor-
mation and instructions that should be provided. The
outcome assessors participated in a one-hour training
session led by the principal investigator (NØ). During
this training, the outcome assessors received instructions
to screen every completed questionnaire for responder
missing while the participant is still present.Intervention
Both the control and intervention groups receive “usual
care”, which for most people in Norway with hand OAExclusion criteria
• Persons with a cognitive dysfunction;
• Persons who do not understand the Norwegian language;
• Persons with inflammatory rheumatic diseases (e.g. rheumatoid arthritis,
ankylosing spondylitis) or cancer;
• Persons who have recently experienced severe trauma;
• Persons who have recently undergone OA surgery or other major surgery;
• Persons who have received steroid injections in their hand joints during
the previous two months.
erformance, 30 = poor activity performance).
Figure 1 Flow diagram of the study protocol.
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referral to a consultation with occupational therapists in
secondary care). During this study, the control group
receives no particular attention, referral or treatment
from the project group, and we expect that none, or only
a few, will consult a health care professional for their
hand OA. Only the intervention group receives the exer-
cise intervention, including the telephone follow-up.
The exercise programme for people with hand OA
was developed in 2010 based on the results from a sys-
tematic review of the design and effects of splints and
exercise programmes, as well as from the American
College of Sports Medicine (ACSM) recommendationsfor developing muscular strength and flexibility in older
frail adults [12,27]. The development of the exercise
programme followed the new Medical Research Council
guidance [28] for developing and evaluating complex
interventions, including pilot testing (manuscript under
review). Exercises 1–3 aim to increase the muscular
strength and stability of the shoulder girdle/upper arm
muscles, as this may influence hand activity perform-
ance. Exercises 4–5 intend to maintain or increase the
flexibility of the MCP, PIP and DIP joints, while exercise
6 aims to strengthen the mm. extensors and abductors
pollicis. The purpose is to maintain the thumb web
space, increase thumb stability and counteract the strong
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increasing the weakness of the opposing thenar intrinsic
musculature, which can be seen in individuals with
CMC1 OA, thereby leading to thumb adduction deform-
ity. Exercise 7 intends to increase grip strength. Pipe
insulation tubes were chosen instead of balls or other
round objects since the tubes allow for squeezing with-
out involving the thumb adductor muscles, which may
contribute to a thumb adduction deformity. For the
same reason, there is no exercise included to increase
the maximum opposition of the thumb (touch the base
of the little finger with the thumb tip) or to strengthen
the pinch or key grip, as such exercises may accelerate
an evolving CMC1-deformity.
The programme starts with a warm-up period consist-
ing of a few minutes of rubbing the hands together and
doing arm swings. Exercises 1 – 7 are performed with
10 repetitions for the first two weeks and 15 repetitions
for weeks 3 – 12 (Table 2). Thera Bands with different
resistance are provided to the participants and tested to
identify the Thera Band with an appropriate, individua-
lised resistance. The rubber band is wrapped around the
hands or around something else if the hand joints are
painful. The participants are instructed to apply a mod-
erate to vigorous intensity in the strengthening exercises
and to gradually progress by adjusting the resistance
(e.g. by shortening the length of the Thera Bands or
changing to a different Thera Band with more resistance).
The intervention group attends one group session per
week and does two home sessions per week in weeks
1–3. During weeks 4–7 and 9–12 they do three sessions
per week on their own. There is a “booster” group ses-
sion in week 8 to ensure adherence and to individually
adjust the exercises. The group sessions last approxi-
mately 45 minutes, and are conducted in the afternoon
in the locations of the Ullensaker Primary Health Care
and at Diakonhjemmet Hospital. SMS reminders are
sent one day in advance, and the intervention group
additionally receives a weekly telephone call in the weeks
without group sessions (weeks 4–7 and 9–12) for indivi-
dualised advice that addresses the exercises and encour-
ages programme adherence.
The intervention group keeps the exercise equipment
after the intervention period and decides themselves if
they want to continue performing the exercise programme.
Moreover, no advice is given to the control group at this
time, but after the 6-month follow-up, the control group is
provided with exercise equipment and instructions in the
exercise programme. The Ullensaker cohort will most
likely be naïve to hand exercises, while some of the Oslo
Hand OA cohort may have received instructions at
Diakonhjemmet Hospital Outpatient Clinic in 2007/2008.
The Oslo Hand OA cohort control group participants will
be asked whether they have received instructions in handexercises before. At the two follow-ups all participants in
the control group will be asked whether they have per-
formed hand exercises in the past 3 months.
Telephone follow-up
The complex process of changing one’s own behaviour
demands both energy and active involvement, and pro-
ceeding as usual often means following the line of least
resistance. Thus, individuals need motivating factors and
support to continue exercising or to establish the habit
of regular exercise [29,30]. Changing health behaviour
with education and advice are positive ways of enabling
persons to exercise regularly, and there is some evidence
which suggests that monthly telephone contact may help
improve the clinical status of people with OA [31]. Ad-
herence to the intervention will be targeted during the
telephone follow-up using Motivational Interview tech-
niques, a client-centred information and motivation
strategy based on cognitive behavioural theory and the
trans-theoretical model [32,33]. It is designed to engage
ambivalent or resistant clients in the process of health
behaviour change, and provides health practitioners with a
means of tailoring their interventions to suit the patient’s
degree of readiness for change.
Outcome measures
The outcome measures have been selected based on
those recommended for clinical trials in patients with
hand OA [34,35], and consist of a combination of pa-
tient self-reported outcomes and performance tests. All
outcome measures are collected at baseline, 3 months
(post-intervention, primary endpoint) and 6 months
(Tables 3 and 4). If a participant is unable to attend the
assessment on the given date (i.e. due to vacation, sick-
ness, etc.), a new appointment is made. For extraordinary
situations (i.e. long-term vacation), the questionnaire is
sent by mail/e-mail or the most important outcome mea-
sures (marked in Table 3) are collected in a telephone
interview.
Primary outcome measures
The primary outcome measure is self-reported hand
activity performance, as measured by the the Functional
Index for Hand OsteoArthritis (FIHOA) [36] and the
Patient-Specific Function Scale (PSFS) [37].
The FIHOA consists of 10 items with a four-point
Likert scale: “possible without difficulty” (0), “possible
with slight difficulty” (1), “possible with important diffi-
culty” (2) and “impossible” (3). In this study, it is used as
a patient self-administered instrument, and a total score
is calculated, with 0 indicating a good performance and
30 indicating a very poor hand activity performance. The
instrument has previously been translated from French
to Norwegian using a forward-backward translation that
Table 2 Exercise programme for people with hand osteoarthritis
No. Exercise illustration* Instructions
1. Shoulder extension: Sit on an armless chair, knees slightly flexed, and
heels on the floor. Start position: hands partly pronated (thumb up),
close to the knees. Pull the exercise band back, as the hands follow the
thigh to the iliac crest.
2. Biceps curl: Stand with the feet shoulder width apart, arms hanging
down. Hands are supinated (thumb laterally). Bend both elbows, pulling
the exercise band towards the shoulders.
3. Shoulder flexion: Stand with the feet shoulder width apart, arms
hanging down. Hands are pronated (thumb medially). Keep the elbows
extended and lift the arms to face level.
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Table 2 Exercise programme for people with hand osteoarthritis (Continued)
4. Make an “O-sign”: Keep the thumb IP and MCP joints slightly flexed
throughout. First, open the hand as if grabbing a bottle. Bring the index
finger tip to the thumb tip, keeping the MCP, PIP and DIP joints flexed.
Open the hand again (“grab the bottle”). Repeat with the 3rd, 4th and
5th fingers.
5. Roll into a fist: First, flex the 2nd to 5th DIPs and PIPs only (keep the
MCPs extended). Then flex the MCPs. Hold for 5 seconds. Reverse:
extend the MCPs only, then the PIPs and DIPs.
6. Thumb abduction/extension: Put one or more small elastic band(s)
around the 1st to 5th proximal phalanges. Rest the loose fist, pronated,
on a flat surface. Keep the thumb MCP and IP joints flexed and abduct/
extend the thumb. Hold for 5 seconds.
7. Grip strength: Squeeze a pipe insulation tube as hard as possible
(isometric hold) for 10 seconds.
8. Finger stretch: Lay the right hand on a flat surface. Use the left hand
to apply firm pressure for 30 seconds stretching the 2nd to 5th PIP and
DIP joints. Repeat 2 times for each hand.
If the finger joints are painful: stretch one finger at a time; place the 2nd
to 4th finger tips (opposite hand) between the finger joints of the 2nd
finger; press for 30 seconds.
*The person on the images has consented for the images to be published.
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for test-retest reliability, validity and responsiveness has
been shown [36,45,46].
The PSFS is a patient-specific instrument commonly
used in assessments and evaluations in musculoskeletal
pain disorders. The instrument is interview-administered,
and the patient is asked to name three to five important
activities that they are unable to do or have difficulty
doing as a result of their problem (in the present study:their hand OA). The patient then scores the difficulty on
an 11-point numeric rating scale (NRS), in which 0 rep-
resents “Unable to perform activity” and 10 “Able to
perform activity at pre-injury/disease level”. The scores
for each activity are used independently and no total
score is calculated. In a recent systematic review, the
instrument’s measurement properties have been found
to be acceptable for several musculoskeletal disorders
[47], and it was found to be responsive in patients with
Table 3 Primary and secondary outcomes
Primary outcome measures: Measurement scale Time*
Hand activity performance (The Functional Index for Hand OsteoArthritis, FIHOA [36]) # 0-30 0, 3, 6
Patient-generated disability (Patient-Specific Function Scale, PSFS [37]) # 0-10 0, 3, 6
Secondary outcome measures:
Hand pain # Numeric rating scale (NRS): 0-10 0, 3, 6
Hand stiffness # Numeric rating scale (NRS): 0-10 0, 3, 6
Patient Global Assessment of disease activity # NRS: 0-10 0, 3, 6
Patient Global Assessment of disease activity affecting activities of daily living # NRS: 0-10 0, 3, 6
Patient Global Assessment of change in disease activity over past three months # 7-point scale 3, 6
Patient Global assessment of change in management of activities of daily living # 5 point scale 3, 6
Grip strength (JAMAR dynamometer) Kilogramme (mean of three repetitions) 0, 3, 6
Hand dexterity (Moberg Pick-up Test [38]) Seconds (right hand, left hand) 0, 3, 6
Thumb web space (Grip Size instrument) Cylinder size: 1–12 cm 0, 3, 6
Health-related quality of life (15D [39]) 0-1 scale 0, 3, 6
*0 = baseline, 3 = 3 months, 6 = 6 months.
# Items included in the telephone interview when attendance is impossible.
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ment in primary care [48].Secondary outcome measures
A number of secondary measures are used (Table 3), in-
cluding an 11-point NRS to obtain self-reported hand
pain, hand stiffness and Patient Global Assessment of
disease activity and disease activity affecting the activities
of daily living. To help capture potential changes at the
3- and 6-month follow-up, 7- and 5-point versions of
the Patient Global Assessment of Change Scales are used
to self-report disease activity and the management of
activities of daily living, respectively.
Maximal grip strength is measured using a Jamar
Dynamometer. The participant sits on an armless chair
with the shoulder in a neutral position and the elbow
90° flexed. A maximal squeeze of the dynamometer is
performed three times for each hand with 15 second
breaks, and the average values for each hand will be
calculated.
A functional performance test, the Moberg Pick-up
Test, is included to help obtain a quantitative assessment
of hand dexterity [38]. The test consists of 12 small
objects that have to be picked up while time is recorded
using a stop watch. The standard protocol by Ng et al. is
applied, and the test is performed once with each hand
and the eyes open. The 12 objects are in accordance
with a description in the paper by Stamm et al. [38].
To measure the thumb web space in a standardised
manner, a Grip Size instrument (12 transparent plexi-
glass cylinders with a diameter from 1 cm to 12 cm) is
used. Participants are asked to grip one cylinder at a
time, and the largest size where the assessor can see fullcontact between the cylinder and the total arch of the
participant’s thumb and second digit is recorded.
The 15D instrument of health-related quality of life
(15D) is a generic, comprehensive, self-administered
instrument that captures 15 dimensions (i.e. mobility,
usual activities, discomfort and symptoms, distress) with
five response categories in each dimension, thereby
making it theoretically possible to further describe the
30 billion health states [39]. A set of utility or preference
weights will be used to generate the 15D score (single
index number) on a 0–1 scale, which will be used as a
utility measure in the cost-utility analysis.
Tertiary outcome measures
At all three time points, the questionnaire includes ques-
tions about bilateral vs. unilateral hand pain and which
hand is the most painful. At both the 3- and 6-month
follow-ups, the individuals report any arm injury, arm
surgery or hand joint injections that have occurred over
the past three months. An 11-point NRS is used to cap-
ture fatigue, while psychological distress at baseline is
measured by the General Health Questionnaire (GHQ-20),
a widely used screening instrument for measuring non-
psychotic psychiatric illness in a general population [40].
Items are scored as the original GHQ score in a bi-modal
fashion (0-0-1-1) [49].
A single question is used to measure self-reported
work ability: “To what degree is your ability to perform
your ordinary work reduced today?”, with the following
response alternatives: hardly reduced at all, not much
reduced, moderately reduced, much reduced and very
much reduced (score range 0–4) [41].
Physical activity is self-reported using the International
Physical Activity Questionnaire-Short Form (IPAQ-SF)
Table 4 Tertiary outcome measures
Tertiary outcome measures Measurement scale Time*
Hand pain in which hand Left/Right/Both 0, 3, 6
Which hand is most painful Left/Right 0, 3, 6
Hand injury, surgery or injections over past three months Single question 3, 6
Fatigue Numeric rating scale (NRS): 0-10 0, 3, 6
Mental distress (General Health Questionnaire, GHQ-20 [40]) Bi-modal fashion (0-0-1-1) 0 months
Self-reported work ability [41] 5-point scale 0, 3, 6
Physical activity (International Physical Activity Questionnaire-Short
Form, IPAQ [42])
Mean minutes/week, MET-minutes/week 0, 3, 6
• Vigorous-intensity activity
• Moderate-intensity activity
• Walking
• Sitting
Exercise self-efficacy [43] 7-point scale 0, 3, 6
Exercise diary (intervention group only) dd.mm.yy 0-3
• Date Minutes
• Exercise duration NRS: 0–10
• Pain level post-exercise Text
• Comments Kilogrammes
• Grip strength at group sessions (weeks 2, 3 and 8)
Adverse events (intervention group only, obtained from the
exercise diary + telephone follow-up log)
Type, duration 0-3
Direct and indirect costs
Self-reported sick leave over past three months Number of days 0, 3, 6
Absence from non-paid work over past three months Number of days 0, 3, 6
Self-reported health-care utilisation over past three months: number of
visits to general practitioner, medical specialist, physiotherapist, manual
therapist, chiropractor, occupational therapist, psychologist,
social worker, nurse at general practice/outpatient clinic,
“alternative therapy”, hospitalisation
Number of visits 0, 3, 6
Pharmacology use for hand OA over past three months Self-reported 0, 3, 6
Medical or technical equipment purchased during the past three months Self-reported
Costs for attending group sessions (only intervention group): distance
travelled, transportation method, transportation costs, work absence,
need for accompaniment
Self-reported 0
Participant characteristic variables
Age Birth year 0
Gender Female/Male 0
Marital status Married or cohabiting/Separated or divorced/
Widowed/Single
0
Education Lower secondary school/Higher secondary school/
University
1–4 years/University >4 years
0
Employment status Working full time/working part time/not working/student/
working full-time in the home/unemployed or seeking work/
age retired/disability pension/sick leave
0
Height Centimetres 0
Weight Kilogrammes 0
Dominant hand Left/Right 0
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Table 4 Tertiary outcome measures (Continued)
Year of OA diagnosis Year 0
Fulfilment of ACR criteria for hand OA Yes/no 0
*0 = baseline, 3 = 3 months, 6 = 6 months.
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determined by the expressed metabolic equivalent task
minutes per week (METs min/wk) of different categories
(sitting, walking, moderate- and vigorous-intensity phys-
ical activity and total physical activity score) and physical
activity levels (low, moderate and high).
In order to examine exercise self-efficacy, a self-
administered questionnaire with 12 statements is used
to evaluate how certain the participants are that they are
capable of sticking to the exercise programme, even
under unfavorable circumstances [43]. The instrument
has a 7-point response scale (range 1–7, higher scores
reflect higher exercise self-efficacy), but only the first-,
middle- and last response options are worded: “Not
certain at all”, “Maybe” and “Very certain”, and a mean
score is calculated.
The intervention groups are asked to keep an exercise
diary that includes a registration of the date and the dur-
ation of each exercise session. The individuals report
their pain level post-exercise and write comments if any.
Maximal grip strength is measured at the group sessions
by one repetition for each hand after warm-up, but be-
fore performing the exercise programme. Based on the
diary notes, the total number of exercise sessions per-
formed will be calculated, and a high compliance will be
defined as attendance at more than 75% (three of four)
of scheduled group exercise sessions and 60% (22 of 36)
of prescribed home exercise sessions in the intervention
group, as described in a previous hip OA exercise trial
protocol [50].
Adverse effects or events
Adverse events related to exercises for people with hand
OA are not consistently studied, but the risk is consid-
ered to be low if the suitability of the exercise for the
individual is appropriately assessed by a trained health
professional [8,51]. Should they occur, adverse events
related to the exercise intervention are documented by
the type and duration, and information on this is col-
lected and registered during telephone counseling and
from the exercise diary.
Direct and indirect costs
Based on a validated cost diary and a previous study
[52,53], a questionnaire was developed to collect infor-
mation on resource use. Number of sick leave days and
absence from non-paid work is reported over the previ-
ous three months. Furthermore, health-care utilisationfor the previous three months is self-reported as number
of visits to relevant health-care providers. They also
report any medication taken for hand OA, as well as
medical or technical equipment purchased during the
past three months. The intervention group fills in an
extra questionnaire targeting costs for attending the
group sessions (i.e. travel distance, transportation method,
public transportation cost if applicable, work absence or
travel escort).
Statistical analyses
Data analysis
Demographic and clinical characteristics as well as other
baseline data are being collected and will be presented
to assess the baseline comparability of the two groups.
These variables will also be compared for those partici-
pants who withdraw from the study and those who remain.
Parametric and non-parametric statistical analysis models
will be used depending on the distribution of the variables.
The intention-to-treat principle (ITT) will be followed
in the primary analyses of data, and will include all par-
ticipants, also those who have missing data and those
who are not fully compliant with the protocol. Descrip-
tive statistics will be presented for each group as the
mean change (standard deviation, 95% confidence inter-
vals) in the outcomes from baseline to each time point.
Differences in mean change from baseline to each time
point will be compared between groups, using linear
mixed models or generalised linear regression modeling,
adjusting for baseline levels of the outcome measure.
Model assumptions will be checked by standard diag-
nostic plots, and improvements in the intervention and
control group based on the perceived ratings of change
will be compared using logistic regression, and presented
as odds ratios with 95% confidence intervals. Addition-
ally, the number of “responders” in the two groups will
be compared using the OMERACT-OARSI responder
criteria [54]. A participant will be classified as a re-
sponder if one of the following is fulfilled:
1) High improvement:
 ≥50% improvement + absolute change of ≥2 in
self-reported hand pain (NRS, 0–10), OR
 ≥50% improvement + absolute change of ≥6 in
self-reported hand activity performance
(FIHOA, 0–30);
OR
2) Improvement in at least 2 of the 3 following:
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self-reported hand pain
 ≥20% improvement + absolute change ≥1 in
Patient Global Assessment of disease activity
(NRS, 0–10)
 ≥20% improvement + absolute change ≥6 in
self-reported hand activity performance (FIHOA)An exploratory sub-group analysis will be completed
to examine the effectiveness of the exercise programme
for those participants attending all group sessions and
performing all home sessions. This analysis will only be
completed if there are sufficient participants attending
all four treatment sessions and performing all home
sessions. Treatment concordance will also be evaluated
descriptively by self-reported exercise frequency and
duration at the 3- and 6-month follow-up.
Exact analyses utilising the binominal distribution will
be used to assess the success of outcome assessor blind-
ing (with 95% confidence intervals); no statistical adjust-
ment will be made for multiple testing, and all tests will
be two-sided and carried out at the 5% level of signifi-
cance. Any changes to the study design or analysis plan
will be documented with full justification.
Health economics
Based on the findings in this study two economic evalu-
ations will be conducted, applying both health system
and societal perspective. Costs in the health-care sector
comprise intervention costs and costs related to treat-
ment and follow-up, while societal costs include produc-
tion loss, as well as costs for the individuals and the
family. The primary economic evaluation will be cost-
utility analysis (CUA) of the cost per extra quality ad-
justed life years (QALYs), which will be calculated using
the 15D scores at 3 and 6 months. The secondary evalu-
ation will be a cost-effectiveness analysis (CEA) based
on the disease-specific measure FIHOA. Incremental
cost per QALY (cost per FIHOA) will be calculated as
the ratio of the difference between groups in mean cost
to the difference in mean QALYs (FIHOAs). By means
of bootstrapping, cost-effectiveness acceptability curves
(CEACs) were used to consider the uncertainty surround-
ing the cost-effectiveness of the exercise programme by
plotting the probability that exercise programme is
cost-effective according to a range of willingness-to-pay
thresholds.
Sample size
The primary outcome measure FIHOA sum score
(range: 0–30 points) was used to estimate sample size.
Using a minimal clinically important change (MIC) of
three points (10%) (sd 6.2), with a significance level of
0.05 (2 tailed) and a power of 80%, we estimated that 68persons will be needed in each group. To allow for a
10% drop-out rate, 75 persons will be included in each
group.
Time schedule
3rd quarter 2010 – 4th quarter 2012: Recruitment of
study participants;
1st quarter 2011 – 1st quarter 2013: Baseline measure-
ments, exercise intervention and telephone follow-up;
4th quarter 2010 – 2nd quarter 2013: The follow-up
measurements;
2nd quarter 2013 – 4th quarter 2013: Data analysis,
writing and submitting articles.
Ethics
The study is conducted according to good clinical prac-
tice, and is in compliance with the Declaration of
Helsinki; and the study was approved by the Regional
Committee for Medical and Health Research Ethics (Ref.
no: 2010/727a) and the Data Inspectorate. The study
participants receive written and oral information about
the study, and written consents are collected prior to the
baseline data collection.
Discussion
The prevalence of hand OA increases with age, and is
growing due to the aging of the population. Since there
are no disease-modifying interventions available and
pharmacological treatment of hand OA is primarily lim-
ited to symptom relief, the effectiveness of non-
pharmacological treatment modalities should be further
explored and documented. Although exercise is recom-
mended as a core treatment for people with OA, to date,
research on the effect of exercise has mainly been per-
formed in people with knee OA, and also hip OA to a
lesser degree. However, available research assessing the
effect of exercises in people with hand OA is very lim-
ited and shows conflicting findings. Lack of gain in
muscle strength in exercise programmes designed to im-
prove grip strength has been previously reported [17,19],
whereas a programme with flexibility exercises resulted
in increased grip strength [15].
Hence high-quality randomised controlled exercise
trials for this patient group are warranted. This paper
outlines a protocol for a pragmatic RCT, including an
exercise intervention with telephone follow-up for people
with hand OA.
Among the strengths of this trial is the implementa-
tion of an exercise programme developed following the
new Medical Research Council guidance for developing
and evaluating complex interventions [28,42]. The devel-
opment followed a systematic approach, using the current
evidence, expert opinions, and involving patient re-
search partners in designing the study and piloting the
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and the equipment required is cheap and easily available
for health care professionals and individuals with hand
OA. Further research is now needed to investigate the
effectiveness of this exercise programme in people with
hand OA.
The intervention effects will be assessed with a com-
bination of validated-, self-reported patient outcome
measures and performance-based observation tests. The
trial measure outcomes for clinical trials recommended
by Osteoarthritis Research Society International (OARSI)
and Outcome Measures in Rheumatological Clinical Trials
(OMERACT) are included in the study. Additionally, we
will record and evaluate the success rate of the assessor
blinding strategy, and perform cost-utility- and cost-
effectiveness analyses to assess the costs and effects of
the exercise intervention compared to usual care.
Some attrition is anticipated despite the fact that we
have planned procedures to minimize loss due to follow-
up and participant withdrawal, and to maximize adher-
ence. This may represent a limitation insofar as the
planned trial does not include a placebo or attention
control intervention for the control group. However, no
optimal solution for the content or delivery of a “sham
exercise intervention” was identified and an educational
intervention for the control group might have resulted
in limited contrasts between the two groups. Hence, this
study is designed as a pragmatic trial comparing the
active intervention with the usual care.
In conclusion, this study will contribute to the know-
ledge of the effect of exercises with telephone follow-up
on self-reported hand activity performance in people
with hand OA, in addition to the cost-utility and cost-
effectiveness of the exercise intervention.
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